Tumour suppressor genes and risk ofmetastasis in ovarian cancer W S Lowry, RJ Atkinson
The silent onset of ovarian cancer often leads to metastatic spread before diagnosis can be made. The cause remains unknown, but molecular studies are beginning to reveal some mechanisms. Inactivation of tumour suppressor genes is thought to be responsible for initiating many forms of cancer. Studies of allele loss indicate areas of genome where inactivation may occur. We recently examined the relation between the clinical stage of epithelial ovarian cancer and allele loss at three loci on chromosome 17: progressive loss was detected with advancing stages of disease.'
The clinical stage of a tumour defines the extent of the disease and is the best determinant of prognosis for most forms of cancer. It depends on the time elapsed before diagnosis, hence the value placed on early detection. The histopathological grade, however, better describes the intrinsic nature of the tumour: well differentiated tumours are slow growing whereas undifferentiated, anaplastic tumours metastasise rapidly. Thus poorly differentiated tumours tend to be diagnosed at a more advanced stage. At the molecular level one might anticipate less damage to genetic material with well differentiated tumours.
Methods and results
We collected 52 fresh specimens of ovarian tumours, ofwhich 38 satisfied the pathological criteria ofinvasive malignant disease. Complete clinical and laboratory data were available for 33 of the cases, but three were homozygous and thus uninformative. The remaining 30 cases were informative at one or more of the three loci examined on chromosome 17 (two polymorphic loci (YNZ22.2 and BHP53) on l7pl3 and one at the THH59 locus (17q23-qer)). DNA was extracted from fresh blood samples and was analysed by Southem blot hybridisation. The tumours were classified histologically into well, moderately, and poorly differentiated lesions according to grades I, II, and III respectively.
The greatest allele loss was seen in grade III tumours at all three loci, with the highest loss of over 90% at THH59) ( The summary data are given in the table. Differences were highly significant between medical schools (X2=92-46; df=26; p<0001) and training regions (x2=100-34; df=23; p<0001). Although medical school and training region were related (42% oftrainees carried out postgraduate training in the same region as their undergraduate training), there are no differences overall between those who stayed in their region for postgraduate training and those who left. Log-linear modelling using the program GLIM (generalised linear interactive modelling) showed that differences between training regions were significant after differences between undergraduate schools were taken into account (X2=56-6; df=23; p<0 001), and differences between undergraduate schools were significant after differences between training regions were taken into account (x2=49 7; df=26; p<001). The rank ordering of schools and regions was little altered by taking into consideration the effect of the other, and the top and bottom six schools and regions remained the same as in the tables.
Comment
The differences shown in the table may well be the result of true differences in the training ability of medical schools and regions. Altemative explanations are, however, not inconceivable. It might, for example, be the case that good students from high scoring medical schools and poor students from the low scoring schools consistently tend to opt for general practice.
The proportions of trainees from the different regions who attempt the examination vary (but the available data on which to calculate these are unsatisfactory 
